Anticancer Therapies – News and Features

According to a study, a dendritic cell vaccine administered before and after autologous stem cell transplant was safe, immunogenic and was associated with durable clinical responses in patients with high-risk multiple myeloma.

A new drug screening tool developed by scientists suggests that a chemotherapy drug used to fight bone marrow cancer has the potential to treat and prevent potentially deadly heart failure.

Engineers have developed a new hydrogel-based delivery system that balances the acidic environment in a tumor and greatly enhances the cancer-fighting activity of the chemotherapeutic drug it encapsulates in lab experiments.

Researchers have discovered how to improve the anti-tumour power of CAR T cells, artificial immune ‘‘super cells’’ used against blood cancers.

Explore the current state of decentralization in cell therapy manufacturing as well as the challenges and future technologies that may define the space.

Triple-negative breast cancer (TNBC) affects 10-15% of patients with breast cancer in the US and is notoriously difficult to treat. Researchers have now discovered a new method to drastically reduce tumor growth even wiping out the cancer completely in some experiments.

A recent study found that over one-third of men aged 15 years and over are infected with at least one type of HPV. In this article, we explore why HPV is not just a women's health issue.

A new study from the Massachusetts Institute of Technology has investigated why checkpoint blockade inhibitors - a type of immunotherapy - don't always work as expected.

Metabolites produced by gut bacteria during digestion can be used to trigger an immune response against colorectal cancer cells, according to new research that points toward a potential treatment for one of the deadliest forms of cancer.

A new drug – tulmimetostat – has been given fast-track approval by the US Food and Drug Administration (FDA) to treat some endometrial cancers – a type of uterine cancer.